Characterization of a novel MYO3A missense mutation associated with a dominant form of late onset hearing loss.
Vitor G L DantasManmeet H RavalAngela BallesterosRunjia CuiLaura K GuntherGuilherme L YamamotoLeandro Ucela AlvesAndré Silva BuenoKarina LezirovitzSulene PiranaBeatriz C A MendesChristopher M YengoBechara KacharRegina C Mingroni-NettoPublished in: Scientific reports (2018)
Whole-exome sequencing of samples from affected members of two unrelated families with late-onset non-syndromic hearing loss revealed a novel mutation (c.2090 T > G; NM_017433) in MYO3A. The mutation was confirmed in 36 affected individuals, showing autosomal dominant inheritance. The mutation alters a single residue (L697W or p.Leu697Trp) in the motor domain of the stereocilia protein MYO3A, leading to a reduction in ATPase activity, motility, and an increase in actin affinity. MYO3A-L697W showed reduced filopodial actin protrusion initiation in COS7 cells, and a predominant tipward accumulation at filopodia and stereocilia when coexpressed with wild-type MYO3A and espin-1, an actin-regulatory MYO3A cargo. The combined higher actin affinity and duty ratio of the mutant myosin cause increased retention time at stereocilia tips, resulting in the displacement of the wild-type MYO3A protein, which may impact cargo transport, stereocilia length, and mechanotransduction. The dominant negative effect of the altered myosin function explains the dominant inheritance of deafness.
Keyphrases
- late onset
- wild type
- early onset
- hearing loss
- binding protein
- intellectual disability
- mitochondrial dna
- induced apoptosis
- protein protein
- single cell
- autism spectrum disorder
- pseudomonas aeruginosa
- gene expression
- escherichia coli
- cell cycle arrest
- dna methylation
- cell death
- cell proliferation
- candida albicans
- genome wide